(Q53515623)

15 May 2018

title

Mechanisms linking tumor cell-associated procoagulant function to tumor metastasis. (English)

1 reference

15 May 2018

1 reference

Joseph S Palumbo

1

1 reference

15 May 2018

Jay L Degen

series ordinal

2

1 reference

15 May 2018

publication date

1 January 2007

1 reference

15 May 2018

published in

Thrombosis Research

1 reference

15 May 2018

volume

120 Suppl 2

1 reference

15 May 2018

page(s)

S22-8

1 reference

15 May 2018

Changes of the coagulation and fibrinolysis system in malignancy: their possible impact on future diagnostic and therapeutic procedures

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2807%2970127-5

7 January 2021

Urokinase-receptor (u-PAR): an essential player in multiple games of cancer: a review on its role in tumor progression, invasion, metastasis, proliferation/dormancy, clinical outcome and minimal residual disease

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2807%2970127-5

7 January 2021

Oncogenes, trousseau syndrome, and cancer-related changes in the coagulome of mice and humans

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2807%2970127-5

7 January 2021

Tissue factor expression and prognosis in patients with metastatic prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2807%2970127-5

7 January 2021

Preoperative serum tissue factor levels are an independent prognostic factor in patients with ovarian carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2807%2970127-5

7 January 2021

The role of tissue factor in colorectal cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2807%2970127-5

7 January 2021

Tissue factor promotes melanoma metastasis by a pathway independent of blood coagulation.

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2807%2970127-5

7 January 2021

Expression of tissue factor by melanoma cells promotes efficient hematogenous metastasis

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2807%2970127-5

7 January 2021

Requirement for binding of catalytically active factor VIIa in tissue factor-dependent experimental metastasis

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2807%2970127-5

7 January 2021

Antitumor and antimetastatic effect of warfarin and heparins.

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2807%2970127-5

7 January 2021

Regulation of vascular endothelial growth factor production and angiogenesis by the cytoplasmic tail of tissue factor

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2807%2970127-5

7 January 2021

Cross-talk of integrin alpha3beta1 and tissue factor in cell migration

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2807%2970127-5

7 January 2021

Formation of tissue factor-factor VIIa-factor Xa complex prevents apoptosis in human breast cancer cells

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2807%2970127-5

7 January 2021

Functional implications of tissue factor localization to cell-cell contacts in myocardium

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2807%2970127-5

7 January 2021

A role for tissue factor in cell adhesion and migration mediated by interaction with actin-binding protein 280.

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2807%2970127-5

7 January 2021

Tissue factor cytoplasmic domain stimulates migration by activation of the GTPase Rac1 and the mitogen-activated protein kinase p38.

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2807%2970127-5

7 January 2021

The cytoplasmic domain of tissue factor contributes to leukocyte recruitment and death in endotoxemia

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2807%2970127-5

7 January 2021

Tissue factor-dependent signaling in tumor biology

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2807%2970127-5

7 January 2021

Tissue factor- and factor X-dependent activation of protease-activated receptor 2 by factor VIIa

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2807%2970127-5

7 January 2021

Mechanistic coupling of protease signaling and initiation of coagulation by tissue factor

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2807%2970127-5

7 January 2021

Thrombin generation and the pathogenesis of cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2807%2970127-5

7 January 2021

Tumor cell-associated tissue factor and circulating hemostatic factors cooperate to increase metastatic potential through natural killer cell-dependent and-independent mechanisms

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2807%2970127-5

7 January 2021

Regulation of angiogenesis by tissue factor cytoplasmic domain signaling

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2807%2970127-5

7 January 2021

Tumor cell adhesion and migration supported by interaction of a receptor-protease complex with its inhibitor

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2807%2970127-5

7 January 2021

Prothrombin deficiency results in embryonic and neonatal lethality in mice

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2807%2970127-5

7 January 2021

Prostacyclin: a potent antimetastatic agent

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2807%2970127-5

7 January 2021

Platelets and cancer metastasis: a causal relationship?

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2807%2970127-5

7 January 2021

Effects of antiplatelet agents alone or in combinations on platelet aggregation and on liver metastases from a human pancreatic adenocarcinoma in the nude mouse

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2807%2970127-5

7 January 2021

Platelets, protease-activated receptors, and fibrinogen in hematogenous metastasis

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2807%2970127-5

7 January 2021

Platelets and fibrin(ogen) increase metastatic potential by impeding natural killer cell-mediated elimination of tumor cells.

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2807%2970127-5

7 January 2021

Potential future clinical applications for the GPIIb/IIIa antagonist, abciximab in thrombosis, vascular and oncological indications

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2807%2970127-5

7 January 2021

Thrombin induces tumor growth, metastasis, and angiogenesis: Evidence for a thrombin-regulated dormant tumor phenotype

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2807%2970127-5

7 January 2021

The thrombin mutant W215A/E217A shows safe and potent anticoagulant and antithrombotic effects in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2807%2970127-5

7 January 2021

Strategies of natural killer cell recognition and signaling.

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2807%2970127-5

7 January 2021

Transforming growth factor-beta controls T helper type 1 cell development through regulation of natural killer cell interferon-gamma

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2807%2970127-5

7 January 2021

Elevated TGF-beta1 secretion and down-modulation of NKG2D underlies impaired NK cytotoxicity in cancer patients

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2807%2970127-5

7 January 2021

Prostaglandin E2 suppressed IL-15-mediated human NK cell function through down-regulation of common gamma-chain

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2807%2970127-5

7 January 2021

Effect of prostaglandin E2 on cytotoxic activity and granzyme A protease release by murine adherent IL-2 activated killer cells

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2807%2970127-5

7 January 2021

Prostaglandin E2 Suppresses NK Activity In Vivo and Promotes Postoperative Tumor Metastasis in Rats

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2807%2970127-5

7 January 2021

10.1016/S0049-3848(07)70127-5

Identifiers

DOI

1 reference

15 May 2018

PubMed ID

18023710

1 reference

15 May 2018